Journal Information
Manuscript Submission:
Subscriptions:
Annual subscription rates: Annual subscription rates are available
online. Subscriptions outside the United States must be prepaid. GST tax of 7% will be added to the subscription price of all orders shipped to Canada. (Wolters Kluwer Health, Inc.’s GST Identification #895524239. Publication Mail Agreement #1119672). Please indicate in-training status and name of institution. Institutional rates apply to libraries, hospitals, corporations, and partnerships of three or more individuals. Prices subject to change without notice. Subscription will begin with currently available issue unless otherwise requested. Copies will be replaced without charge if the publisher receives a request within 90 days of the mailing date. Individual and in-training subscription rates include print and access to the online version. Institutional rates are for print only; online subscriptions are available through Ovid. Please contact the Ovid Regional Sales Office near you for more information on institutional online access. Visit
https://shop.lww.com/resources-librarian for contact information.
Address for member subscription information, orders, or change of address: To become a member or provide change of address, contact the American College of Obstetricians and Gynecologists, 409 12th Street SW, P.O. Box 96920, Washington, DC 20090-6920; fax 202-479-0054; email
[email protected]. For all other member inquiries, contact Wolters Kluwer Health Inc.’s Customer Service Department, P.O. Box 1610, Hagerstown, MD 21740; phone 800-638-3030 (outside the U.S. 301-223-2300); fax 301-223-2400; email
[email protected].
Address for nonmember subscription information, orders, or change of address: P.O. Box 1610, Hagerstown, MD 21740. phone 800-638-3030 or 301-223-2300; fax 301-223-2400. In Japan, contact Wolters Kluwer Health Japan Co., LTD., Forecast Mita Building 5th Floor, 1-3-31 Mita Minato-ku, Tokyo Japan 108-0073 Tel: 81 3 5427 1969.
Permissions and Reprints:
Permission to photocopy articles: This publication is protected by copyright. Permission to reproduce copies of articles for noncommercial use may be obtained from the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923.
Reprints: Quantities of reprints greater than 100 for commercial or academic use may be purchased from Lippincott Williams & Wilkins. For information and prices contact Meredith Edelman at 215-521-8300; email
[email protected].
Advertising:
Advertising inquiries: Display: Tanya Wilson, Wolters Kluwer Health/Lippincott Williams & Wilkins; phone (410) 776-5890; email:
[email protected].
Classified: Ryan Magee, Wolters Kluwer Health/Lippincott Williams & Wilkins; phone 215-521-8404; email:
[email protected].
The appearance of advertising in publications of the American College of Obstetricians and Gynecologists (and/or in exhibits at meetings of ACOG) does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made for it by its manufacturer. Furthermore, reference to a product within a paper published by ACOG does not constitute a guarantee or endorsement of that product or its manufacturer’s claims. The fact that a product, service, or company is advertised in a publication, cited in a paper, or exhibited at a meeting of ACOG shall not be referred to by the manufactur-er in collateral advertising.
All advertisements are subject to the approval of the Editor and the American College of Obstetricians and Gynecologists. The Editor reserves the right to decline or refuse advertisements at any time.
Pharmaceutical advertisements must be approved by the FDA for specific uses and indications. Product claims should be based on published data and, preferably, the reference to the studies should appear on the advertisement. Advertisements may be refused in the event that new copy is discovered to be inconsistent with previously approved advertisements and their indications or use. Teaser ads, such as “Coming Soon,” may be acceptable prior to FDA approval but may not list implied indications or dosage and may only show the name of the product or the name of the parent company consistent with DDMAC guidelines. Products and services that are of interest to physicians as practitioners, business-persons and consumers, are generally acceptable. These products and services include medical equipment, services, medical software, practice management products/services, and medical websites. The Editor determines the eligibility of advertising on products intended for pre-ventative, diagnostic, or therapeutic purposes.
Hinari:
Obstetrics & Gynecology participates in the Health InterNetwork Access to Research Initiative (HINARI). Academic, research,
and government institutions in qualifying countries may obtain information at https://partnership.who.int/hinari.
